bw 12c79 has been researched along with Adenocarcinoma, Basal Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Littlewood, T; van Rhee, F; Ware, I | 1 |
| Bedford, P; Bleehen, NM; Dennis, I; Falk, SJ; Nethersell, AB; Ramsay, JR; Ward, R; Wootton, R; Workman, P | 1 |
| Cole, S; Robbins, L | 1 |
1 trial(s) available for bw 12c79 and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Drug Evaluation; Gastrointestinal Neoplasms; Hemoglobins; Humans; Middle Aged; Mitomycin; Oxygen | 1992 |
2 other study(ies) available for bw 12c79 and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Abnormal haemoglobin electrophoresis caused by BW 12C.
Topics: Adenocarcinoma; Anemia, Sickle Cell; Antineoplastic Agents; Benzaldehydes; Blood Protein Electrophoresis; False Negative Reactions; Hemoglobins; Humans; Male; Middle Aged | 1992 |
Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Hydralazine; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Oxidation-Reduction; Oxygen; Radiation-Sensitizing Agents; Radiotherapy; Transplantation, Heterologous | 1989 |